<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Evonik Industries Ag — News on 6ix</title>
    <link>https://6ix.com/company/evonik-industries-ag</link>
    <description>Latest news and press releases for Evonik Industries Ag on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 13 Nov 2025 17:47:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/evonik-industries-ag" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69da1be6d20c3ebdd611ce4d.webp</url>
      <title>Evonik Industries Ag</title>
      <link>https://6ix.com/company/evonik-industries-ag</link>
    </image>
    <item>
      <title>Kelyniam Global Secures Exclusive U.S. License for Evonik&apos;s VESTAKEEP® Fusion Biomaterial in Cranial Implants</title>
      <link>https://6ix.com/company/evonik-industries-ag/news/kelyniam-global-secures-exclusive-us-license-for-evoniks-vestakeepr-fusion-biomaterial-in-cranial-implants-1</link>
      <guid isPermaLink="true">https://6ix.com/company/evonik-industries-ag/news/kelyniam-global-secures-exclusive-us-license-for-evoniks-vestakeepr-fusion-biomaterial-in-cranial-implants-1</guid>
      <pubDate>Thu, 13 Nov 2025 17:47:00 GMT</pubDate>
      <description>CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from Evonik Industries AG to market VESTAKEEP® Fusion, a bi-calcium phosphate-infused PEEK material, for cranial, craniofacial, and maxillofacial implants. This agreement grants Kelyniam two years of exclusivity with the option for renewal upon mutual agreement. The license enhances Kelyniam&apos;s regenerati</description>
    </item>
  </channel>
</rss>